We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.51B
AUM Growth
+$620M
Cap. Flow
+$586M
Cap. Flow %
38.86%
Top 10 Hldgs %
20.25%
Holding
396
New
278
Increased
36
Reduced
41
Closed
8

Top Buys

Rank Stock Value
1
GDRX icon
GoodRx Holdings
GDRX
+$34.4M
2
THO icon
Thor Industries
THO
+$24.3M
3
LHCG
LHC Group LLC
LHCG
+$22M
4
LH icon
Labcorp
LH
+$21.2M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$21.2M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$19.6M
2
INMD icon
InMode
INMD
+$19M
3
BEAT
BioTelemetry, Inc.
BEAT
+$18M
4
DXCM icon
DexCom
DXCM
+$11.4M
5
FUTU icon
Futu Holdings
FUTU
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.22%
2 Consumer Discretionary 13.83%
3 Financials 12.23%
4 Technology 6.87%
5 Communication Services 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
26
Allogene Therapeutics
ALLO
$714M
$18.9M 1.26%
+536,738
New +$18.1M
UNH icon
27
UnitedHealth
UNH
$364B
$18.9M 1.25%
50,801
– –
HALO icon
28
Halozyme
HALO
$11.6B
$18.8M 1.24%
450,000
-20,000
-4% -$913K
TXG icon
29
10x Genomics
TXG
$7.52B
$17.9M 1.19%
+99,061
New +$17.1M
NEO icon
30
NeoGenomics
NEO
$2.11B
$17.5M 1.16%
+362,842
New +$18.9M
ELS icon
31
Equity Lifestyle Properties
ELS
$12.4B
$17.2M 1.14%
270,000
– –
MED icon
32
Medifast
MED
$130M
$16.9M 1.12%
80,000
-30,000
-27% -$7.18M
INDA icon
33
iShares MSCI India ETF
INDA
$6.58B
$16.9M 1.12%
401,200
-12,000
-3% -$504K
MRNA icon
34
Moderna
MRNA
$25.4B
$16.7M 1.11%
+127,704
New +$18.5M
NTRA icon
35
Natera
NTRA
$45.5B
$16.6M 1.1%
+163,278
New +$17.9M
APLS
36
DELISTED
Apellis Pharmaceuticals
APLS
$16.3M 1.08%
+379,395
New +$18M
TRHC
37
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$15.9M 1.05%
+344,334
New +$16.4M
TCOM icon
38
Trip.com Group
TCOM
$28.7B
$15.6M 1.03%
392,865
-94,340
-19% -$3.49M
TAL icon
39
TAL Education Group
TAL
$6.58B
$15.3M 1.01%
283,348
+75,268
+36% +$5.51M
IMGN
40
DELISTED
Immunogen Inc
IMGN
$15M 0.99%
+1,849,772
New +$15.1M
AAPL icon
41
Apple
AAPL
$4.41T
$14.6M 0.97%
119,630
+351
+0.3% +$45.1K
NBIX icon
42
Neurocrine Biosciences
NBIX
$15.9B
$14.6M 0.97%
+149,864
New +$15.7M
GTHX
43
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$14.5M 0.96%
+601,591
New +$14M
DRNA
44
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$13.5M 0.89%
+526,058
New +$13.4M
TWST icon
45
Twist Bioscience
TWST
$7.85B
$13.3M 0.88%
+107,403
New +$16.3M
MDRX
46
DELISTED
Veradigm Inc. Common Stock
MDRX
$12.6M 0.84%
+839,521
New +$13.4M
NVAX icon
47
Novavax
NVAX
$1.31B
$12M 0.8%
+66,402
New +$13.2M
NVTA
48
DELISTED
Invitae Corporation
NVTA
$11.6M 0.77%
+303,596
New +$13.8M
MSFT icon
49
Microsoft
MSFT
$3.66T
$11.6M 0.77%
49,132
+1,057
+2% +$245K
NBIS
50
Nebius Group N.V.
NBIS
$65.8B
$11.5M 0.76%
179,760
+32,300
+22% +$2.16M
1
2
3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q1 2021 Portfolio in Review

As of Q1 2021, Lombard Odier Asset Management (Switzerland) held 396 positions worth $1.51B, up 70% from $887M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lombard Odier Asset Management (Switzerland) deployed $586M of net new capital in Q1 2021, opening 278 new positions and adding to 36 existing holdings. Its largest new stake was GoodRx Holdings: 764,779 shares worth $29.8M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Futu Holdings, an estimated $10.1M trimmed.

  • Lombard Odier Asset Management (Switzerland)'s largest Q1 2021 buy was GoodRx Holdings: 764,779 shares worth $29.8M.
  • Lombard Odier Asset Management (Switzerland) added most to Exact Sciences in Q1 2021, an estimated $19.8M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $10.1M.
  • Lombard Odier Asset Management (Switzerland) fully exited HILL-ROM HOLDINGS, INC. in Q1 2021, selling an estimated $19.6M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 20% of its $1.51B portfolio in Q1 2021.
  • Lombard Odier Asset Management (Switzerland) opened 278 new positions and closed 8 in Q1 2021.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value rose 70% quarter-over-quarter to $1.51B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2021, filed 17 May 2021.